Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 6:18 PM View:  | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Payment of Exercise | 3,622 | $6.03 | $21,840.70 | (< 1%) 6.02M to 6.02M | |
| 20-Nov-24 6:23 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 13,432 | -- | -- | 25% 53.92K to 67.35K | |
| 20-Nov-24 6:21 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 40,639 | -- | -- | < 1% 5.16M to 5.2M | |
| 20-Nov-24 6:25 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Payment of Exercise | 1,460 | $6.03 | $8,803.80 | (10%) 14.33K to 12.87K | |
| 20-Nov-24 6:18 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 14,869 | -- | -- | < 1% 6.01M to 6.02M | |
| 20-Nov-24 6:19 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Payment of Exercise | 2,015 | $6.03 | $12,150.50 | (3%) 62.0K to 59.98K | |
| 20-Nov-24 6:25 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 3,746 | -- | -- | 35% 10.59K to 14.33K | |
| 20-Nov-24 6:23 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Payment of Exercise | 4,499 | $6.03 | $27,129.00 | (7%) 67.35K to 62.85K | |
| 20-Nov-24 6:16 PM View: | Holder Michael Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 2,181 | -- | -- | 150% 1.45K to 3.63K | |
| 20-Nov-24 6:21 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Payment of Exercise | 9,897 | $6.03 | $59,678.90 | (< 1%) 5.2M to 5.19M | |
| 20-Nov-24 6:19 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 18-Nov-24 | Option Exercise | 5,171 | -- | -- | 9% 56.83K to 62.0K | |
| 16-Sep-24 6:26 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 14-Sep-24 | Gift | 200,000 | -- | -- | (4%) 5.36M to 5.16M | |
| 21-Aug-24 6:15 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 3,746 | -- | -- | 45% 8.3K to 12.04K | |
| 21-Aug-24 6:21 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 10,766 | -- | -- | 109% 9.9K to 20.67K | |
| 21-Aug-24 6:26 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 5,046 | $5.53 | $27,904.40 | (9%) 58.96K to 53.92K | |
| 21-Aug-24 6:19 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 5,171 | -- | -- | 10% 53.67K to 58.84K | |
| 21-Aug-24 6:22 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 3,731 | $5.53 | $20,632.40 | (< 1%) 6.01M to 6.01M | |
| 21-Aug-24 6:26 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 13,432 | -- | -- | 30% 45.53K to 58.96K | |
| 21-Aug-24 6:28 PM View: | Holder Michael Director | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 1,454 | -- | -- | 100% 0 to 1.45K | |
| 21-Aug-24 6:24 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 40,639 | -- | -- | < 1% 5.33M to 5.37M | |
| 21-Aug-24 6:15 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 1,460 | $5.53 | $8,073.80 | (12%) 12.04K to 10.59K | |
| 21-Aug-24 6:21 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 4,195 | $5.53 | $23,198.40 | (20%) 20.67K to 16.47K | |
| 21-Aug-24 6:22 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Option Exercise | 14,869 | -- | -- | < 1% 6.0M to 6.01M | |
| 21-Aug-24 6:24 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 9,897 | $5.53 | $54,730.40 | (< 1%) 5.37M to 5.36M | |
| 21-Aug-24 6:19 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 19-Aug-24 | Payment of Exercise | 2,015 | $5.53 | $11,143.00 | (3%) 58.84K to 56.83K | |
| 22-May-24 6:28 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 3,168 | $5.96 | $18,881.30 | (28%) 11.47K to 8.3K | |
| 22-May-24 6:34 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 2,927 | $5.96 | $17,444.90 | (23%) 12.83K to 9.9K | |
| 22-May-24 6:36 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 10,572 | -- | -- | < 1% 5.99M to 6.0M | |
| 22-May-24 6:32 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 7,102 | $5.96 | $42,327.90 | (< 1%) 5.33M to 5.33M | |
| 22-May-24 6:41 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 1,447 | $5.96 | $8,624.12 | (3%) 55.12K to 53.67K | |
| 22-May-24 6:28 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 8,132 | -- | -- | 244% 3.33K to 11.47K | |
| 22-May-24 6:34 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 7,512 | -- | -- | 141% 5.32K to 12.83K | |
| 22-May-24 6:31 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 3,751 | $5.96 | $22,356.00 | (8%) 45.8K to 42.04K | |
| 22-May-24 6:32 PM View: | Jiang Wenbin President and CEO Director | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 29,345 | -- | -- | < 1% 5.3M to 5.33M | |
| 22-May-24 6:41 PM View: | Poirson Allen SVP Bus. and Corp. Dev. | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 3,711 | -- | -- | 7% 51.41K to 55.12K | |
| 22-May-24 6:31 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Option Exercise | 9,626 | -- | -- | 27% 36.17K to 45.8K | |
| 22-May-24 6:36 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 20-May-24 | Payment of Exercise | 3,137 | $5.96 | $18,696.50 | (< 1%) 6.0M to 6.0M | |
| 23-Apr-24 6:07 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Apr-24 | Sale (Planned) | 20,000 | $5.87 | $117,400.00 | (< 1%) 6.01M to 5.99M | |
| 11-Apr-24 6:17 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 09-Apr-24 | Sale (Planned) | 1,900 | $7.00 | $13,304.00 | (< 1%) 6.01M to 6.01M | |
| 21-Mar-24 6:19 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-Mar-24 | Payment of Exercise | 2,129 | $6.70 | $14,264.30 | (39%) 5.46K to 3.33K | |
| 21-Mar-24 6:19 PM View: | Busque Philippe SVP, Global Sales and Services | Cytek Biosciences, Inc. (CTKB) | 20-Mar-24 | Option Exercise | 5,464 | -- | -- | 100% 0 to 5.46K | |
| 19-Mar-24 6:25 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 19-Mar-24 | Sale (Planned) | 20,000 | $6.71 | $134,200.00 | (< 1%) 6.03M to 6.01M | |
| 19-Mar-24 6:25 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 18-Mar-24 | Sale (Planned) | 20,000 | $6.77 | $135,400.00 | (< 1%) 6.05M to 6.03M | |
| 13-Mar-24 6:55 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 9,817 | -- | -- | < 1% 6.04M to 6.05M | |
| 13-Mar-24 6:39 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 4,908 | -- | -- | 15% 33.17K to 38.08K | |
| 13-Mar-24 6:44 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 1,912 | $7.22 | $13,804.60 | (2%) 99.38K to 97.47K | |
| 13-Mar-24 6:44 PM View: | Jeanmonod Patrik Chief Financial Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Option Exercise | 4,908 | -- | -- | 5% 94.47K to 99.38K | |
| 13-Mar-24 6:39 PM View: | Barnett Valerie CHIEF LEGAL OFFICER | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 1,912 | $7.22 | $13,804.60 | (5%) 38.08K to 36.17K | |
| 13-Mar-24 6:55 PM View: | Yan Ming Chief Technology Officer Director | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 2,911 | $7.22 | $21,017.40 | (< 1%) 6.05M to 6.05M | |
| 13-Mar-24 6:53 PM View: | Williams Paul Christopher Chief Operating Officer | Cytek Biosciences, Inc. (CTKB) | 11-Mar-24 | Payment of Exercise | 478 | $7.22 | $3,451.16 | (8%) 5.79K to 5.32K |
